Pharma mutual funds have emerged as the best-performing sectoral category across multiple time periods, including the last three months, six months, and in the current calendar year so far, an analysis by ETMutualFunds showed. However, after such a strong run, investors are wondering whether the sector can continue to outperform over the next 12 to 18 months or whether expectations have already been priced into stock prices.
Market experts said this performance was driven by strong earnings, improving export prospects, resilient domestic demand, and investors' preference for defensive sectors amid an uncertain global environment.
